Study title: The bronchodilator efficacy of Berotec tablets as measured after single doses (day 1) by comparison with the standard therapeutic agent (ephedrine) with particular emphasis on onset of action and duration of action. 2. The persistence of bronchodila...
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: IPRATROPIUM | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: E74-577 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |